|
|
|
|
|
|
|
Poster: 282
Visits: 129
Title: Everolimus plus R-CHOP as initial therapy for DLBCL: a phase I/feasibility study (NCCTG N1085 Alliance)
Authors: Patrick Johnston , Thomas Habermann
Centre: Mayo Clinic
|
|
You must be registered to reply or comment.
|
|
EVEROLIMUS PLUS R-CHOP AS INITIAL THERAPY FOR DLBCL: A PHASE I/FEASIBILITY STUDY (NCCTG N1085 ALLIANCE)
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 154
Visits: 188
Title: NR4A3 suppresses lymphomagenesis by induction of apoptosis and serves as a drug target for lymphoma therapy
Authors: Alexander Deutsch ,
Centre: Clinical Devision of Hematology
|
|
|
|